Ryuichi Morishita

6PUBLICATIONS
26CO-AUTHORS
BiomaterialsGene and molecular therapySensory systemsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 04, 2024
A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts.

Shota Yoshida, Hiroki Hayashi, Takuro Kawahara

|Oct 02, 2024
Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease.

Hironori Nakagami, Hiroki Hayashi, Ryuichi Morishita

|May 11, 2023
R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice.

Munehisa Shimamura, Hiroki Hayashi, Nan Ju

|Apr 28, 2023
Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.

Masayoshi Suda, Ippei Shimizu, Goro Katsuumi

|May 20, 2020
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice.

Shota Yoshida, Hironori Nakagami, Hiroki Hayashi

|Aug 29, 2018
Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice.

Munehisa Shimamura, Hironori Nakagami, Hideo Shimizu

Pageof 1

Frequent Collaborators

5 joint publications

Hironori Nakagami

4 joint publications

Munehisa Shimamura

3 joint publications

Shota Yoshida

3 joint publications

Hiroki Hayashi